KYNAMRO Risk Evaluation and Mitigation Strategy (REMS) is an FDA-required program to educate healthcare providers and patients in order to ensure that KYNAMRO is prescribed only to patients for whom the benefits outweigh the risks.
KYNAMRO Risk Evaluation and Mitigation Strategy (REMS) is an FDA-required program to educate healthcare providers and patients in order to ensure that KYNAMRO is prescribed only to patients for whom the benefits outweigh the risks.